These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15841888)

  • 1. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty.
    Briggs A
    Value Health; 2005; 8(1):1-2. PubMed ID: 15841888
    [No Abstract]   [Full Text] [Related]  

  • 2. Who's better not best: appropriate probabilistic uncertainty analysis.
    Coyle D
    Int J Technol Assess Health Care; 2003; 19(3):540-5. PubMed ID: 12962341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
    Hazen GB; Huang M
    Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric modelling of cost data in medical studies.
    Nixon RM; Thompson SG
    Stat Med; 2004 Apr; 23(8):1311-31. PubMed ID: 15083485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
    Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
    Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Handling uncertainty of the economic evaluation result: sensitivity analysis.
    Limwattananon S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S59-65. PubMed ID: 19253488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
    Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
    Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products.
    Wen S; Zhang L; Yang B
    Value Health; 2014 Jul; 17(5):619-28. PubMed ID: 25128056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs.
    Brisson M; Edmunds WJ
    Med Decis Making; 2006; 26(5):434-46. PubMed ID: 16997923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.
    Briggs A; Fenn P
    Health Econ; 1998 Dec; 7(8):723-40. PubMed ID: 9890333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).
    Barton GR; Briggs AH; Fenwick EA
    Value Health; 2008; 11(5):886-97. PubMed ID: 18489513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis.
    Lord J; Asante MA
    Health Econ; 1999 Jun; 8(4):323-33. PubMed ID: 10398525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis.
    Stevenson MD; Oakley J; Chilcott JB
    Med Decis Making; 2004; 24(1):89-100. PubMed ID: 15005958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Handling uncertainty in cost-effectiveness models.
    Briggs AH
    Pharmacoeconomics; 2000 May; 17(5):479-500. PubMed ID: 10977389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The handling of uncertainty in economic evaluations of health care strategies].
    Siani C; Moatti JP
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):255-76. PubMed ID: 12876511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cost-effectiveness of transcatheter versus surgical closure of secundum atrial septal defect in adults.
    Mylotte D; Quenneville SP; Kotowycz MA; Xie X; Brophy JM; Ionescu-Ittu R; Martucci G; Pilote L; Therrien J; Marelli AJ
    Int J Cardiol; 2014 Mar; 172(1):109-14. PubMed ID: 24485223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined analysis of uncertainty and patient heterogeneity in medical decision models.
    Groot Koerkamp B; Stijnen T; Weinstein MC; Hunink MG
    Med Decis Making; 2011; 31(4):650-61. PubMed ID: 20974904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods.
    O'Brien BJ; Briggs AH
    Stat Methods Med Res; 2002 Dec; 11(6):455-68. PubMed ID: 12516984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods.
    Stollenwerk B; Stock S; Siebert U; Lauterbach KW; Holle R
    Med Decis Making; 2010; 30(3):304-13. PubMed ID: 19815659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding probabilistic analysis and computationally expensive models: necessary and required?
    Caro JJ; Getsios D; Möller J
    Value Health; 2007; 10(4):317-8; author reply 319. PubMed ID: 17645686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.